John is an international health care leader in measurement, health policy, health systems, and quality of clinical care. He has contributed to more than 200 peer-reviewed publications and several books on quality, measurement, economics and healthcare systems. An actively funded National Institutes of Health (NIH) researcher, John works with clinical leaders, academic medical centers and multidisciplinary teams to help healthcare organizations better align their clinical staff. For almost two decades, he has examined how health systems affect, and potentially improve, care quality and patient outcomes. His leadership in this arena has led to his placement on Institute of Medicine and NIH committees and World Health Organization task forces. He has also testified before Congress on these issues. John developed the globally adopted standard for measuring clinical practice variation, known now simply as CPV Vignettes, the pillar stone of QURE Healthcare.
Read more about John Peabody
Dr. Burgon is a nationally recognized leader in healthcare strategy and has worked extensively with senior health system leaders across the country on projects ranging from demand forecasting and value-based payment structures to clinical technology assessment and cancer center development. In addition, Trever speaks frequently at national conferences on issues on of quality and value in healthcare. Before joining QURE, Trever served as Vice President at Sg2 (now a division of MedAssets), a health care analytics and intelligence company. At Sg2, Trever led the firm’s Center for Clinical Technology as well as the Oncology Strategy team. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his BS from Brigham Young University.
Vice President of Sales and Product Strategy
Scott FitzSimons has over 25 years of experience working strategically in multiple healthcare settings. He has dedicated his career to the advancement of healthcare education, knowledge and practice. Mr. FitzSimons has already successfully grown two enterprises generating impressive revenue and investment results. Prior to QURE, Scott led the Big Data and Analytics Channel partnership efforts at Health Language, a division of Wolters Kluwer. Through his efforts and leadership, the Health Language solution components are part of the solution stacks of many leading analytics and data warehouse vendors today. Health Language is recognized today as the leading provider of enterprise terminology interoperability. At Elsevier, he ran business development efforts for the four business units that comprised their Clinical Decision Support division. Under his direction, ECDS formed strategic content, distribution, and international relationships that continue to drive business today.
Manager of Business Development
Othman joined QURE in November 2012. Othman has previous experience working in consulting policy analysis, project implementation support and other strategic business services to healthcare provider and information technology organizations. His services primarily focus on healthcare reform, health policy and health information technology.
Prior to joining QURE, Othman also served as a research assistant while attending Stanford University, where he engaged in the analysis and compilation of data on U.S. medical start-up acquisitions. He also served as a health system analyst with The Public Health Institute where he worked with health systems to plan and implement their community benefit programs, as well as completed a healthcare policy fellowship with The Bell Policy Center.
Director of Analytics and Research
As Director of Analytics and Research at QURE Healthcare, David is responsible for planning and executing data analyses related to QURE’s core business, as well as guiding and overseeing the overall analytics and statistical modeling projects of the analytics team. David received his Master of Public Health from Dartmouth College in 2003, with an emphasis in quality improvement and biostatistics, and a Bachelor of Science in Electrical Engineering from the University of California, Irvine. David has over ten years of experience related to healthcare analysis and outcomes, and he has been a contributing author to over a dozen peer-reviewed articles. Prior to this, he worked in semiconductor technology at IBM, where he fulfilled several technical and information technology roles for US and international clients to enable the success of a multiple projects.
Dr. Diana Tamondong-Lachica is the Physician Lead of QURE Healthcare, Inc. She is a practicing general internist, an educator, and an advocate. She obtained her medical degree from the University of the Philippines College of Medicine in 2007, finishing as the Class Valedictorian and in the same year, she placed 3rd in the Physician Licensure Exam. She did her residency training and chief residency for Internal Medicine in the Philippine General Hospital, the premiere health care training institution in the Philippines. She is a lecturer in UP College of Medicine, Ateneo School of Medicine and Public Health and the San Beda College of Medicine. She is an advocate and teacher of evidence-based medicine and has done consultancy work for health policy and implementation as well.
Director of Clinical Programs
As Director of Clinical Programs, Mary oversees study development and quality assurance across each of QURE’s program pillars: health care providers, life sciences and global health. Mary brings experience as a health strategist and management consultant, with significant market access, pricing, and reimbursement experience, advising both health care providers and life sciences companies. In previous roles, she also tracked emerging trends impacting oncology service line management in the US as well as market access and marketing in Latin America, Europe and Asia.